The Role of <i>BRCA1/2</i>-Mutated Tumor Microenvironment in Breast Cancer

by Svetlana Miklikova, Lenka Trnkova, Jana Plava, Martin Bohac, Marcela Kuniakova, Marina Cihova
Published 2021-02-01

Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer

by Jana Plava, Marina Cihova, Monika Burikova, Miroslava Matuskova, Lucia Kucerova, Svetlana Miklikova
Published 2019-03-01

Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients

by Zuzana Cierna, Bozena Smolkova, Dana Cholujova, Paulina Gronesova, Svetlana Miklikova, Marina Cihova, Jana Plava, Michal Mego
Published 2021-01-01

Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer

by Svetlana Miklikova, Gabriel Minarik, Tatiana Sedlackova, Jana Plava, Marina Cihova, Silvia Jurisova, Katarina Kalavska, Marian Karaba, Juraj Benca, Bozena Smolkova, Michal Mego
Published 2020-05-01

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells

by Silvia Schmidtova, Katarina Kalavska, Katarina Gercakova, Zuzana Cierna, Svetlana Miklikova, Bozena Smolkova, Verona Buocikova, Viera Miskovska, Erika Durinikova, Monika Burikova, Michal Chovanec, Miroslava Matuskova, Michal Mego, Lucia Kucerova
Published 2019-08-01

Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy

by Jana Plava, Marina Cihova, Monika Burikova, Martin Bohac, Marian Adamkov, Slavka Drahosova, Dominika Rusnakova, Daniel Pindak, Marian Karaba, Jan Simo, Michal Mego, Lubos Danisovic, Lucia Kucerova, Svetlana Miklikova
Published 2020-02-01

Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer

by Jana Plava, Monika Burikova, Marina Cihova, Lenka Trnkova, Bozena Smolkova, Pavel Babal, Lucia Krivosikova, Pavol Janega, Lucia Rojikova, Slavka Drahosova, Martin Bohac, Lubos Danisovic, Lucia Kucerova, Svetlana Miklikova
Published 2021-09-01

Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines

by Silvia Schmidtova, Katarina Kalavska, Veronika Liskova, Jana Plava, Svetlana Miklikova, Lucia Kucerova, Miroslava Matuskova, Lucia Rojikova, Zuzana Cierna, Adriana Rogozea, Heiko Konig, Costantine Albany, Michal Mego, Michal Chovanec
Published 2021-04-01

Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients

by Bozena Smolkova, Zuzana Cierna, Katarina Kalavska, Svetlana Miklikova, Jana Plava, Gabriel Minarik, Tatiana Sedlackova, Dana Cholujova, Paulina Gronesova, Marina Cihova, Karolina Majerova, Marian Karaba, Juraj Benca, Daniel Pindak, Jozef Mardiak, Michal Mego
Published 2020-12-01

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness

by Silvia Schmidtova, Lambert C. J. Dorssers, Katarina Kalavska, Ad J. M. Gillis, J. Wolter Oosterhuis, Hans Stoop, Svetlana Miklikova, Zuzana Kozovska, Monika Burikova, Katarina Gercakova, Erika Durinikova, Michal Chovanec, Michal Mego, Lucia Kucerova, Leendert H. J. Looijenga
Published 2020-08-01

Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives

by Verona Buocikova, Ivan Rios-Mondragon, Eleftherios Pilalis, Aristotelis Chatziioannou, Svetlana Miklikova, Michal Mego, Karlis Pajuste, Martins Rucins, Naouale El Yamani, Eleonora Marta Longhin, Arkadij Sobolev, Muriel Freixanet, Victor Puntes, Aiva Plotniece, Maria Dusinska, Mihaela Roxana Cimpan, Alena Gabelova, Bozena Smolkova
Published 2020-12-01